Cargando…
Tackling dipeptidyl peptidase IV in neurological disorders
Dipeptidyl peptidase IV (DPP-IV) is a serine protease best known for its role in inactivating glucagon-like peptide-1 (GLP-1), pituitary adenylate cyclase-activating polypeptide (PACAP) and glucose-dependent insulinotropic peptide (GIP), three stimulators of pancreatic insulin secretion with benefic...
Autores principales: | Al-Badri, Ghaith, Leggio, Gian Marco, Musumeci, Giuseppe, Marzagalli, Rubina, Drago, Filippo, Castorina, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840985/ https://www.ncbi.nlm.nih.gov/pubmed/29451201 http://dx.doi.org/10.4103/1673-5374.224365 |
Ejemplares similares
-
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
por: Musumeci, Giuseppe, et al.
Publicado: (2018) -
Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?
por: Castorina, Alessandro, et al.
Publicado: (2015) -
Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications
por: Marzagalli, Rubina, et al.
Publicado: (2015) -
PACAP Interacts with PAC(1) Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures
por: Castorina, Alessandro, et al.
Publicado: (2015) -
Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020)